首页 > 最新文献

Nihon Kessen Shiketsu Gakkai shi = Japanese journal of thrombosis and hemostasis最新文献

英文 中文
血小板活性化受容体CLEC-2の基礎研究から臨床応用に向けた取り組み 从血小板活化受体CLEC-2的基础研究到临床应用的努力
Katsue Suzuki-Inoue, N. Tsukiji, Toshiaki Shirai, Tomoyuki Sasaki
{"title":"血小板活性化受容体CLEC-2の基礎研究から臨床応用に向けた取り組み","authors":"Katsue Suzuki-Inoue, N. Tsukiji, Toshiaki Shirai, Tomoyuki Sasaki","doi":"10.2491/jjsth.34.414","DOIUrl":"https://doi.org/10.2491/jjsth.34.414","url":null,"abstract":"","PeriodicalId":89444,"journal":{"name":"Nihon Kessen Shiketsu Gakkai shi = Japanese journal of thrombosis and hemostasis","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69242398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Description of the principles and applications of clot waveform analysis (CWA) and clot fibrinolysis waveform analysis (CFWA) 血块波形分析(CWA)和血块纤溶波形分析(CFWA)的原理和应用
Tomoko Matsumoto, Daiki Shimomura
{"title":"Description of the principles and applications of clot waveform analysis (CWA) and clot fibrinolysis waveform analysis (CFWA)","authors":"Tomoko Matsumoto, Daiki Shimomura","doi":"10.2491/jjsth.34.43","DOIUrl":"https://doi.org/10.2491/jjsth.34.43","url":null,"abstract":"","PeriodicalId":89444,"journal":{"name":"Nihon Kessen Shiketsu Gakkai shi = Japanese journal of thrombosis and hemostasis","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69243029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human constitutive androstane receptor represses liver cancer development and hepatoma cell proliferation by inhibiting erythropoietin signaling. 人类组成型雄甾烷受体通过抑制促红细胞生成素信号传导抑制肝癌发展和肝癌细胞增殖。
Pub Date : 2022-05-01 Epub Date: 2022-03-30 DOI: 10.1016/j.jbc.2022.101885
Zhihui Li, So Mee Kwon, Daochuan Li, Linhao Li, Xiwei Peng, Junran Zhang, Tatsuya Sueyoshi, Jean-Pierre Raufman, Masahiko Negishi, Xin Wei Wang, Hongbing Wang

The constitutive androstane receptor (CAR) is a nuclear receptor that plays a crucial role in regulating xenobiotic metabolism and detoxification, energy homeostasis, and cell proliferation by modulating the transcription of numerous target genes. CAR activation has been established as the mode of action by which phenobarbital-like nongenotoxic carcinogens promote liver tumor formation in rodents. This paradigm, however, appears to be unrelated to the function of human CAR (hCAR) in hepatocellular carcinoma (HCC), which remains poorly understood. Here, we show that hCAR expression is significantly lower in HCC than that in adjacent nontumor tissues and, importantly, reduced hCAR expression is associated with a worse HCC prognosis. We also show overexpression of hCAR in human hepatoma cells (HepG2 and Hep3B) profoundly suppressed cell proliferation, cell cycle progression, soft-agar colony formation, and the growth of xenografts in nude mice. RNA-Seq analysis revealed that the expression of erythropoietin (EPO), a pleiotropic growth factor, was markedly repressed by hCAR in hepatoma cells. Addition of recombinant EPO in HepG2 cells partially rescued hCAR-suppressed cell viability. Mechanistically, we showed that overexpressing hCAR repressed mitogenic EPO-EPO receptor signaling through dephosphorylation of signal transducer and activator of transcription 3, AKT, and extracellular signal-regulated kinase 1/2. Furthermore, we found that hCAR downregulates EPO expression by repressing the expression and activity of hepatocyte nuclear factor 4 alpha, a key transcription factor regulating EPO expression. Collectively, our results suggest that hCAR plays a tumor suppressive role in HCC development, which differs from that of rodent CAR and offers insight into the hCAR-hepatocyte nuclear factor 4 alpha-EPO axis in human liver tumorigenesis.

组成型雄烷受体(CAR)是一种核受体,通过调节众多靶基因的转录,在调节异生物代谢和解毒、能量平衡和细胞增殖方面发挥着至关重要的作用。CAR 激活已被确定为苯巴比妥类非致癌物质促进啮齿类动物肝脏肿瘤形成的作用模式。然而,这种模式似乎与人类 CAR(hCAR)在肝细胞癌(HCC)中的功能无关,人们对这种功能的了解仍然很少。在这里,我们发现 hCAR 在 HCC 中的表达明显低于邻近的非肿瘤组织,重要的是,hCAR 表达的降低与 HCC 预后的恶化有关。我们还发现,在人肝癌细胞(HepG2 和 Hep3B)中过表达 hCAR 能有效抑制细胞增殖、细胞周期进展、软凝胶集落形成以及裸鼠异种移植的生长。RNA-Seq 分析表明,hCAR 能显著抑制肝癌细胞中促红细胞生成素(EPO)(一种多向生长因子)的表达。在 HepG2 细胞中加入重组 EPO 可以部分缓解 hCAR 对细胞活力的抑制。从机理上讲,我们发现过表达 hCAR 可通过信号转导和激活转录 3、AKT 和细胞外信号调节激酶 1/2 的去磷酸化抑制有丝分裂原 EPO-EPO 受体信号转导。此外,我们还发现 hCAR 通过抑制肝细胞核因子 4α 的表达和活性来下调 EPO 的表达,而肝细胞核因子 4α 是调节 EPO 表达的关键转录因子。总之,我们的研究结果表明,hCAR 在 HCC 的发展过程中起着抑制肿瘤的作用,这一点与啮齿类动物的 CAR 不同,并为我们深入了解 hCAR-肝细胞核因子 4 alpha-EPO 轴在人类肝脏肿瘤发生过程中的作用提供了依据。
{"title":"Human constitutive androstane receptor represses liver cancer development and hepatoma cell proliferation by inhibiting erythropoietin signaling.","authors":"Zhihui Li, So Mee Kwon, Daochuan Li, Linhao Li, Xiwei Peng, Junran Zhang, Tatsuya Sueyoshi, Jean-Pierre Raufman, Masahiko Negishi, Xin Wei Wang, Hongbing Wang","doi":"10.1016/j.jbc.2022.101885","DOIUrl":"10.1016/j.jbc.2022.101885","url":null,"abstract":"<p><p>The constitutive androstane receptor (CAR) is a nuclear receptor that plays a crucial role in regulating xenobiotic metabolism and detoxification, energy homeostasis, and cell proliferation by modulating the transcription of numerous target genes. CAR activation has been established as the mode of action by which phenobarbital-like nongenotoxic carcinogens promote liver tumor formation in rodents. This paradigm, however, appears to be unrelated to the function of human CAR (hCAR) in hepatocellular carcinoma (HCC), which remains poorly understood. Here, we show that hCAR expression is significantly lower in HCC than that in adjacent nontumor tissues and, importantly, reduced hCAR expression is associated with a worse HCC prognosis. We also show overexpression of hCAR in human hepatoma cells (HepG2 and Hep3B) profoundly suppressed cell proliferation, cell cycle progression, soft-agar colony formation, and the growth of xenografts in nude mice. RNA-Seq analysis revealed that the expression of erythropoietin (EPO), a pleiotropic growth factor, was markedly repressed by hCAR in hepatoma cells. Addition of recombinant EPO in HepG2 cells partially rescued hCAR-suppressed cell viability. Mechanistically, we showed that overexpressing hCAR repressed mitogenic EPO-EPO receptor signaling through dephosphorylation of signal transducer and activator of transcription 3, AKT, and extracellular signal-regulated kinase 1/2. Furthermore, we found that hCAR downregulates EPO expression by repressing the expression and activity of hepatocyte nuclear factor 4 alpha, a key transcription factor regulating EPO expression. Collectively, our results suggest that hCAR plays a tumor suppressive role in HCC development, which differs from that of rodent CAR and offers insight into the hCAR-hepatocyte nuclear factor 4 alpha-EPO axis in human liver tumorigenesis.</p>","PeriodicalId":89444,"journal":{"name":"Nihon Kessen Shiketsu Gakkai shi = Japanese journal of thrombosis and hemostasis","volume":"18 1","pages":"101885"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052153/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91303751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The utility of comprehensive coagulation assays 综合凝血试验的应用
S. Furukawa, K. Nogami
{"title":"The utility of comprehensive coagulation assays","authors":"S. Furukawa, K. Nogami","doi":"10.2491/jjsth.33.356","DOIUrl":"https://doi.org/10.2491/jjsth.33.356","url":null,"abstract":"","PeriodicalId":89444,"journal":{"name":"Nihon Kessen Shiketsu Gakkai shi = Japanese journal of thrombosis and hemostasis","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69236342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disseminated intravascular coagulation in obstetrics: Diagnosis and up-to-date management strategies 产科弥散性血管内凝血:诊断和最新的管理策略
K. Kawasaki
{"title":"Disseminated intravascular coagulation in obstetrics: Diagnosis and up-to-date management strategies","authors":"K. Kawasaki","doi":"10.2491/jjsth.33.544","DOIUrl":"https://doi.org/10.2491/jjsth.33.544","url":null,"abstract":"","PeriodicalId":89444,"journal":{"name":"Nihon Kessen Shiketsu Gakkai shi = Japanese journal of thrombosis and hemostasis","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69237878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of VTE and prevention project after Kumamoto Earthquakes 熊本地震后VTE患病率及防治方案
K. Sakamoto, S. Hokimoto, Y. Hashimoto, K. Hanzawa, K. Tsujita
要約:2016年 4月,2度の地震(震度 7)が熊本地方を襲った.本震から 2日後,車中泊の 51歳女性が急性肺 塞栓症(pulmonary thromboembolism: PTE)により死亡し,我々は避難所巡回での深部静脈血栓症スクリーニン グ検診を開始した.車中泊者を中心に要入院重症VTE患者が多数発生する中,のべ 136会場で 4,135名に下肢 静脈エコー検診を行なった.急性期検診(発災後 45日間)のDVT陽性率は 9.5%.予後調査で健診による 3名 の要入院者を同定できたが,死亡例はなかった.慢性期検診の検討では,DVT陽性率の検診時期毎の低下傾向 を認めなかったが,高齢者を除くと経時的な陽性率低下が確認できた.急性期に同定されたDVTの慢性期推移 を検討した結果,56%に消失が確認できた.血栓消失群における消失時期について検討したところ,49%は 2ヶ月以内,87%は 6ヶ月以内の追跡で血栓の消失が確認できており,発災直後からの予防啓発活動の重要性 が示唆された.
摘要:2016年4月,熊本地区遭受了两次地震(震度7)。主震发生两天后,一名住在车里的51岁女性因急性肺栓塞(pulmonary thromboembolism, PTE)死亡,我们开始在避难所巡回进行深静脉血栓筛查。在以车内住宿者为中心的需要住院的重症VTE患者大量发生的情况下,共在136个会场对4,135人进行了下肢静脉回声检查。急性期检查(灾后45天)的DVT阳性率为9.5%.在预后调查中确定了3名需要住院的体检者,但没有死亡病例。在慢性期检查的研究中,虽然没有发现DVT阳性率在每个检查时期都有下降的趋势,但排除老年人后,可以确认阳性率随时间的下降。对鉴定为急性期的DVT的慢性期变化进行研究的结果,56%的DVT消失。对血栓消失组的消失时间进行了研究,发现49%在2个月以内、87%在6个月以内的跟踪确认了血栓的消失,提示了在发生灾害之后立即进行预防宣传活动的重要性。
{"title":"Prevalence of VTE and prevention project after Kumamoto Earthquakes","authors":"K. Sakamoto, S. Hokimoto, Y. Hashimoto, K. Hanzawa, K. Tsujita","doi":"10.2491/jjsth.33.648","DOIUrl":"https://doi.org/10.2491/jjsth.33.648","url":null,"abstract":"要約:2016年 4月,2度の地震(震度 7)が熊本地方を襲った.本震から 2日後,車中泊の 51歳女性が急性肺 塞栓症(pulmonary thromboembolism: PTE)により死亡し,我々は避難所巡回での深部静脈血栓症スクリーニン グ検診を開始した.車中泊者を中心に要入院重症VTE患者が多数発生する中,のべ 136会場で 4,135名に下肢 静脈エコー検診を行なった.急性期検診(発災後 45日間)のDVT陽性率は 9.5%.予後調査で健診による 3名 の要入院者を同定できたが,死亡例はなかった.慢性期検診の検討では,DVT陽性率の検診時期毎の低下傾向 を認めなかったが,高齢者を除くと経時的な陽性率低下が確認できた.急性期に同定されたDVTの慢性期推移 を検討した結果,56%に消失が確認できた.血栓消失群における消失時期について検討したところ,49%は 2ヶ月以内,87%は 6ヶ月以内の追跡で血栓の消失が確認できており,発災直後からの予防啓発活動の重要性 が示唆された.","PeriodicalId":89444,"journal":{"name":"Nihon Kessen Shiketsu Gakkai shi = Japanese journal of thrombosis and hemostasis","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69238359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practical key points of VWF multimer analysis VWF多频分析的实用要点
Yuka Eura
{"title":"Practical key points of VWF multimer analysis","authors":"Yuka Eura","doi":"10.2491/jjsth.33.707","DOIUrl":"https://doi.org/10.2491/jjsth.33.707","url":null,"abstract":"","PeriodicalId":89444,"journal":{"name":"Nihon Kessen Shiketsu Gakkai shi = Japanese journal of thrombosis and hemostasis","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69239227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A research life in Scripps Research 在斯克里普斯研究所的研究生涯
Y. Morodomi
{"title":"A research life in Scripps Research","authors":"Y. Morodomi","doi":"10.2491/jjsth.33.712","DOIUrl":"https://doi.org/10.2491/jjsth.33.712","url":null,"abstract":"","PeriodicalId":89444,"journal":{"name":"Nihon Kessen Shiketsu Gakkai shi = Japanese journal of thrombosis and hemostasis","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69239966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Congratulatory speech—The road to TMA analysis in Japan with Professor Miyata’s group— 致贺词-与宫田教授小组一起探索日本的TMA分析之路-
Yoshihiro Fujimura
{"title":"Congratulatory speech—The road to TMA analysis in Japan with Professor Miyata’s group—","authors":"Yoshihiro Fujimura","doi":"10.2491/jjsth.33.718","DOIUrl":"https://doi.org/10.2491/jjsth.33.718","url":null,"abstract":"","PeriodicalId":89444,"journal":{"name":"Nihon Kessen Shiketsu Gakkai shi = Japanese journal of thrombosis and hemostasis","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69240298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibody testing as the guide to our living with COVID-19 抗体检测作为我们与COVID-19生活的指南
N. Kaku, Y. Nakagama, Y. Nitahara, Y. Kido
{"title":"Antibody testing as the guide to our living with COVID-19","authors":"N. Kaku, Y. Nakagama, Y. Nitahara, Y. Kido","doi":"10.2491/jjsth.33.338","DOIUrl":"https://doi.org/10.2491/jjsth.33.338","url":null,"abstract":"","PeriodicalId":89444,"journal":{"name":"Nihon Kessen Shiketsu Gakkai shi = Japanese journal of thrombosis and hemostasis","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69235736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nihon Kessen Shiketsu Gakkai shi = Japanese journal of thrombosis and hemostasis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1